Webcast/CME - Respiratory Synctial Virus (RSV): Prevention Strategies and the Appropriate Identification of Vulnerable Populations

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Respiratory Infections

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Respiratory Infections

	Drug-Resistant TB
	Addressing the Burden of Respiratory Syncytial Virus
	Emergence of Methicillin-Resistant Staphylococcus aureus
	Pulmonary Complications of Anti-Tumor Necrosis Factor-a Therapy
	Current Issues in the Management of Respiratory Tract Congestion

Recent news - Respiratory Infections

	TopAbstracts in Respiratory Infections 12/21/2009 - (DGNews)
	TopAbstracts in Respiratory Infections 12/07/2009 - (DGNews)
	Autopsies Show H1N1 Virus Damages Entire Respiratory Airway - (DGNews)
	Study: Infections Common in ICUs Worldwide - (DGNews)
	TopAbstracts in Respiratory Infections 11/23/2009 - (DGNews)

Recent cases - Respiratory Infections

	Platypnea And Orthodeoxia Associated With Pneumocystis Jiroveci And Cytomegalovirus Pneumonia: A Case Report
	Pulmonary Coccidioidomycosis: Import Illness And The Importance Of Travel History
	Gradual Progression of Interstitial Pneumonia Induced by Bepridil
	A 19-Year-Old Man with Progressive Lung Infiltrates
	Cholecystopleural Fistula in a 71-Year-Old Man with Symptoms of Pneumonia and Pleural Effusion

personal edition > respiratory infections > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Respiratory Synctial Virus (RSV): Prevention Strategies and the Appropriate Identification of Vulnerable Populations

Presented by:	The Chatham Institute
Lecturer	Several lecturers
Approximate duration:	Not available
Summary points:	In this text-based CME program, participants will learn the epidemiology, burden of disease, and seasonal and regional variability of respiratory syncytial virus (RSV); vulnerable populations; preventive strategies; and the therapeutic approaches available to manage RSV.
Accreditation:	The Chatham Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Chatham Institute designates this educational activity for a maximum of 1.50 AMA PRA Category 1 Credits. The Chatham Institute is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.50 contact hours (0.150 CEU) of continuing education for pharmacists. ACPE Universal Program Number (UPN): 812-000-08-024-H01-P Expiration date: November 20, 2009.
Other:	Text-only CE/CME.

Additional Information